3-乙酰基-6-甲基庚烷-2,4-二酮 | 6303-07-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-乙酰基-6-甲基庚烷-2,4-二酮
• 英文名称: 3-acetyl-6-methyl-heptane-2,4-dione
• 英文别名: 3-Acetyl-6-methyl-heptan-2,4-dion；3-Acetyl-6-methylheptane-2,4-dione
• CAS: 6303-07-7
• 化学式: C₁₀H₁₆O₃
• 分子量: 184.235
• InChiKey: AWFTWXYWQXPBMR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  51.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  乙烯酮 、 6-甲基-2,4-庚二酮 在 苯 、 过氧化苯甲酰 作用下， 生成 3-乙酰基-6-甲基庚烷-2,4-二酮
  参考文献：
  名称：

  Method for production of triketones

  摘要：

  公开号：

  US02569132A1

文献信息

• A PERK KINASE INHIBITOR FOR TREATING DISEASES ASSOCIATED WITH ENDOPLASMIC RETICULUM STRESS
  申请人：Uniwersytet Medyczny w Lodzi

  公开号：EP3815682A1

  公开（公告）日：2021-05-05

  The object of the present invention is a compound for use as a medicament, a compound for use as the PERK kinase inhibitor for preventing and treating diseases associated with endoplasmic reticulum stress. Preferably, those diseases are selected from a group including glaucoma, Alzheimer's disease, Parkinson's disease.

  本发明的目的是一种用作药物的化合物，一种用作 PERK 激酶抑制剂的化合物，用于预防和治疗与内质网应激有关的疾病。优选地，这些疾病选自包括青光眼、阿尔茨海默病、帕金森病在内的一组疾病。
• ANT4 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
  申请人：Terada Naohiro

  公开号：US20110230564A1

  公开（公告）日：2011-09-22

  The invention relates to methods for inducing male contraception and to methods of treating cell proliferation related disorders or diseases, such as cancer. The invention further relates to pharmaceutical compositions for inducing male contraception and for treating cell proliferation related disorders or diseases.
• [EN] ANT4 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS INHIBITEURS D'ANT4 ET LEURS PROCÉDÉS D'UTILISATION
  申请人：UNIV FLORIDA

  公开号：WO2010014253A2

  公开（公告）日：2010-02-04

  The invention relates to methods for inducing male contraception and to methods of treating cell proliferation related disorders or diseases, such as cancer. The invention further relates to pharmaceutical compositions for inducing male contraception and for treating cell proliferation related disorders or diseases.
• Method for production of triketones
  申请人：SHELL DEV

  公开号：US02569132A1

  公开（公告）日：1951-09-25